AI diagnostics market seen reaching $31.31B by 2030

The Business Research Company says the artificial intelligence market in medical diagnostics will grow from $5.97 billion in 2025 to $31.31 billion by 2030, driven by chronic disease burden, digitization and wider clinical adoption. North America led in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Artificial intelligence in diagnostics is moving from early adoption to a larger role in clinical workflows. - The market outlook points to faster disease detection, more automated decision support and broader use of AI across imaging and pathology. - The growth trajectory matters for health systems facing rising chronic disease rates and staff shortages.

What happened: - The Business Research Company projected the AI in diagnostic market will rise from $5.97 billion in 2025 to $8.32 billion in 2026. - The report says the market is expected to reach $31.31 billion by 2030. - The company forecast a 39.5% CAGR for 2025-2026 and a 39.3% CAGR through 2030. - The report was released Nov. 3, 2026, in London. - The company also made the report available through the full report and a free sample.

The details: - The report links recent growth to more medical imaging data, broader digitization of healthcare records, a shortage of skilled diagnosticians and better healthcare IT infrastructure. - The forecast cites stronger demand for early disease detection, more investment in AI-powered healthcare tools and wider use of personalized medicine. - The report says regulatory approvals for AI-based diagnostic tools are also supporting growth. - Emerging trends include AI-driven diagnostic imaging, machine learning for clinical decision support, integration with radiology and pathology, predictive analytics and faster diagnostic workflows. - The report defines AI in diagnostics as using algorithms, machine learning and data analytics to interpret medical images, clinical information and other health data. - The stated goal is to improve diagnostic accuracy, efficiency and speed while supporting better patient outcomes. - Rising chronic disease burden is a major growth driver in the report. - The World Health Organization reported in September 2023 that chronic diseases cause about 41 million deaths annually, or 74% of global non-communicable disease deaths. - The WHO figures cited 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases and 2 million from diabetes each year. - North America held the largest share of the AI in diagnostic market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables.

Between the lines: - The forecast suggests AI diagnostics is shifting from a technology story to a workflow and reimbursement story, with regulation and clinical integration becoming as important as model performance. - North America's lead reflects mature healthcare infrastructure, while Asia-Pacific's growth points to expanding access and faster digitization. - The chronic disease data underscores why diagnostic automation has broad commercial appeal beyond imaging alone.

What's next: - Wider regulatory approvals could accelerate adoption of AI diagnostic tools. - More AI integration in radiology and pathology is likely as health systems look for faster and more accurate workflows. - Continued investment in healthcare AI should keep pressure on vendors to prove clinical value, not just technical capability. - The company says broader strategic coverage in its 2026 reports is designed to track those changes through updated analytics and forecasting tools.